JP Morgan Chase
TRIB

JP Morgan Chase’s Trinity Biotech TRIB Stock Holding History

JP Morgan Chase’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Hold
0
– – – 6961
2021
Q3 		– Hold
0
– – – 6806
2017
Q4 		– Sell
-14,461
Closed -$405K – 5578
2017
Q3 		$405K Sell
14,461
-4,979
-26% -$139K ﹤0.01% 3898
2017
Q2 		$583K Sell
19,440
-19,071
-50% -$540K ﹤0.01% 3661
2017
Q1 		$1.15M Sell
38,511
-595
-2% -$18.6K ﹤0.01% 3344
2016
Q4 		$1.35M Buy
39,106
+37,455
+2,269% +$1.29M ﹤0.01% 3299
2016
Q3 		$109K Buy
1,651
+80
+5% +$4.98K ﹤0.01% 3844
2016
Q2 		$89K Hold
1,571
– – ﹤0.01% 3897
2016
Q1 		$92K Buy
+1,571
New +$83.4K ﹤0.01% 3770

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return

JP Morgan Chase's TRIB Position: Q4 2021 in Review

JP Morgan Chase held its Trinity Biotech (TRIB) position steady in Q4 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6961.

JP Morgan Chase first reported a position in TRIB in Q1 2016 and has held it in 7 quarters since. The position peaked at $1.35M in Q4 2016. 21 funds tracked by Wall St. Rank hold TRIB as of Q4 2021.

  • JP Morgan Chase held 0 shares of Trinity Biotech worth $0 as of Q4 2021.
  • JP Morgan Chase left its Trinity Biotech share count unchanged in Q4 2021.
  • Trinity Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q4 2021, its #6961 holding.
  • JP Morgan Chase first reported a position in Trinity Biotech in Q1 2016 and has held it in 7 quarters since.
  • JP Morgan Chase's Trinity Biotech position peaked at $1.35M in Q4 2016.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2021.

Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.